1,25-Dihydroxyvitamin D 3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells

Immunology

Volumn 134, Issue 4, 2011, Pages 459-468

  Khoo, Ai Leng ^a,b   Joosten, Irma ^a,b   Michels, Meta ^b   Woestenenk, Rob ^c   Preijers, Frank ^c   He, Xue Hui ^a,b   Netea, Mihai G ^b   van der Ven, André J A M ^b   Koenen, Hans J P M ^a,b  

^a Laboratory Medical Immunology   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Laboratory of Haematology   (Netherlands)

Author keywords

1,25 dihydroxyvitamin D 3; Cholecalciferol; Forkhead box protein 3; HIV; Immunomodulation; Regulatory T cells

Indexed keywords

CALCITRIOL; COLECALCIFEROL; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; VITAMIN D RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL PROLIFERATION; CELLS, CULTURED; HIV INFECTIONS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES, REGULATORY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80355142089     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03507.x     Document Type: Article

References (40)

1. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92:4-8.
2. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89:922-32.
3. 3 receptor in the immune system. Arch Biochem Biophys 2000; 374:334-8.
4. Hewison M, Freeman L, Hughes SV et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170:5382-90.
5. Sigmundsdottir H, Pan J, Debes GF et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8:285-93.
6. van EE, Mathieu C. Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005; 97:93-101.
7. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15:2579-85.
8. 3 analogs as immunomodulatory agents. Trends Mol Med 2002; 8:174-9.
9. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4:404-12.
10. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006; 92:60-4.
11. 3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005; 146:1956-64.
12. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006; 92:49-59.
13. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev 2006; 64:226-33.
14. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2:816-22.
15. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212:8-27.
16. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9:1144-50.
17. Chattopadhyay S, Chakraborty NG, Mukherji B. Regulatory T cells and tumor immunity. Cancer Immunol Immunother 2005; 54:1153-61.
18. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
19. Piemonti L, Monti P, Sironi M et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164:4443-51.
20. Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009; 70:345-52.
21. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603-16.
22. 3 or dexamethasone: differential role for PD-L1. Eur J Immunol 2009; 39:3147-59.
23. 3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183:5458-67.
24. + cells is enabled by IL-2. J Invest Dermatol 2010; 130:2368-76.
25. + cells to modulate T helper type 2-driven asthmatic responses. Immunology 2010; 130:181-92.
26. Royal W III, Mia Y, Li H, Naunton K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 2009; 213:135-41.
27. Smolders J, Thewissen M, Peelen E et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009; 4:e6635.
28. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945-53.
29. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324:23-33.
30. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010; 11:344-9.
31. Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405-11.
32. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984; 74:1451-5.
33. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1, 25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134:3032-5.
34. Muller K, Odum N, Bendtzen K. 1, 25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 1993; 35:177-82.
35. + cells. Autoimmunity 1992; 14:37-43.
36. Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1, 25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987; 79:1659-64.
37. + T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974-80.
38. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229:1136-42.
39. Imazeki I, Matsuzaki J, Tsuji K, Nishimura T. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res 2006; 27:1-9.
40. Tran TA, de Goer de Herve MG, Hendel-Chavez H et al. Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy. PLoS ONE 2008; 3:e3305.